Extra-respiratory manifestations of COVID-19

被引:216
作者
Lai, Chih-Cheng [1 ]
Ko, Wen-Chien [2 ]
Lee, Ping-Ing [3 ,4 ]
Jean, Shio-Shin [5 ,6 ,8 ]
Hsueh, Po-Ren [7 ]
机构
[1] Kaohsiung Vet Gen Hosp, Tainan Branch, Dept Internal Med, Tainan, Taiwan
[2] Natl Cheng Kung Univ, Dept Med, Coll Med, Tainan, Taiwan
[3] Natl Taiwan Univ, Childrens Hosp, Dept Pediat, Taipei, Taiwan
[4] Natl Taiwan Univ, Coll Med, Taipei, Taiwan
[5] Taipei Med Univ, Sch Med, Dept Emergency, Coll Med, Taipei, Taiwan
[6] Taipei Med Univ, Wan Fang Hosp, Dept Emergency & Crit Care Med, Dept Emergency Med, Taipei, Taiwan
[7] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Lab Med, Taipei, Taiwan
[8] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Internal Med, Taipei, Taiwan
关键词
COVID-19; SARS-CoV-2; Epidemiology; Extra-respiratory manifestations; CORONAVIRUS; DISEASE; PNEUMONIA; RECEPTOR; WUHAN;
D O I
10.1016/j.ijantimicag.2020.106024
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global health threat. Although most patients with COVID-19 manifest fever and respiratory tract symptoms, SARS-CoV-2 infection may also involve other organs/systems and present with extra-respiratory manifestations, including cardiac, gastrointestinal, hepatic, renal, neurological, ol-factory, gustatory, ocular, cutaneous and haematological symptoms. Occasionally, these extra-respiratory symptoms/signs represent the initial presentation of SARS-CoV-2 infection, prior to fever or respiratory manifestations. Therefore, this comprehensive review of the extra-respiratory manifestations of COVID-19 is intended to help clinicians better understand the range of clinical presentations associated with SARS-CoV-2 infection, allowing the consideration of COVID-19 in differential diagnoses. A screening test for SARS-CoV-2 should be performed when patients have these extra-respiratory manifestations. In addition, clinicians should be alerted to the adverse effects of anti-SARS-CoV-2 agents that can mimic the extra -respiratory manifestations of COVID-19. Moreover, some extra-respiratory manifestations, such as ocular and gastrointestinal involvement, may be caused by direct invasion of SARS-CoV-2. Therefore, protec-tive measures should be taken while managing the associated clinical specimens. Finally, several extra-respiratory manifestations, such as cardiac involvement, acute kidney injury, coagulation disorders and thrombotic complications, could be associated with a poor prognosis. (C) 2020 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.
引用
收藏
页数:6
相关论文
共 68 条
  • [21] Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19)
    Inciardi, Riccardo M.
    Lupi, Laura
    Zaccone, Gregorio
    Italia, Leonardo
    Raffo, Michela
    Tomasoni, Daniela
    Cani, Dario S.
    Cerini, Manuel
    Farina, Davide
    Gavazzi, Emanuele
    Maroldi, Roberto
    Adamo, Marianna
    Ammirati, Enrico
    Sinagra, Gianfranco
    Lombardi, Carlo M.
    Metra, Marco
    [J]. JAMA CARDIOLOGY, 2020, 5 (07) : 819 - 824
  • [22] Treatment options for COVID-19: The reality and challenges
    Jean, Shio-Shin
    Lee, Ping-Ing
    Hsueh, Po-Ren
    [J]. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2020, 53 (03) : 436 - 443
  • [23] Kimmis BD, 2018, CUTIS, V102, P353
  • [24] Incidence of thrombotic complications in critically ill ICU patients with COVID-19
    Klok, F. A.
    Kruip, M. J. H. A.
    van der Meer, N. J. M.
    Arbous, M. S.
    Gommers, D. A. M. P. J.
    Kant, K. M.
    Kaptein, F. H. J.
    Van Paassen, J.
    Stals, M. A. M.
    Huisman, M. V.
    Endeman, H.
    [J]. THROMBOSIS RESEARCH, 2020, 191 : 145 - 147
  • [25] Cardiac and arrhythmic complications in patients with COVID-19
    Kochi, Adriano Nunes
    Tagliari, Ana Paula
    Forleo, Giovanni Battista
    Fassini, Gaetano Michele
    Tondo, Claudio
    [J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2020, 31 (05) : 1003 - 1008
  • [26] Global epidemiology of coronavirus disease 2019 (COVID-19): disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status
    Lai, Chih-Cheng
    Wang, Cheng-Yi
    Wang, Ya-Hui
    Hsueh, Shun-Chung
    Ko, Wen-Chien
    Hsueh, Po-Ren
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 55 (04)
  • [27] Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths
    Lai, Chih-Cheng
    Liu, Yen Hung
    Wang, Cheng-Yi
    Wang, Ya-Hui
    Hsueh, Shun-Chung
    Yen, Muh-Yen
    Ko, Wen-Chien
    Hsueh, Po-Ren
    [J]. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2020, 53 (03) : 404 - 412
  • [28] Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges
    Lai, Chih-Cheng
    Shih, Tzu-Ping
    Ko, Wen-Chien
    Tang, Hung-Jen
    Hsueh, Po-Ren
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 55 (03)
  • [29] Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study
    Lechien, Jerome R.
    Chiesa-Estomba, Carlos M.
    De Siati, Daniele R.
    Horoi, Mihaela
    Le Bon, Serge D.
    Rodriguez, Alexandra
    Dequanter, Didier
    Blecic, Serge
    El Afia, Fahd
    Distinguin, Lea
    Chekkoury-Idrissi, Younes
    Hans, Stephane
    Lopez Delgado, Irene
    Calvo-Henriquez, Christian
    Lavigne, Philippe
    Falanga, Chiara
    Barillari, Maria Rosaria
    Cammaroto, Giovanni
    Khalife, Mohamad
    Leich, Pierre
    Souchay, Christel
    Rossi, Camelia
    Journe, Fabrice
    Hsieh, Julien
    Edjlali, Myriam
    Carlier, Robert
    Ris, Laurence
    Lovato, Andrea
    De Filippis, Cosimo
    Coppee, Frederique
    Fakhry, Nicolas
    Ayad, Tareck
    Saussez, Sven
    [J]. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2020, 277 (08) : 2251 - 2261
  • [30] Letko M, 2020, NAT MICROBIOL, V5, P562, DOI [10.1038/s41564-020-0688-y, 10.1101/2020.01.22.915660]